Stock Symbol


News & Events

APT Medical as a Ruby sponsor of MLCTO 2022

04 Jul 2022

The 7th edition of the Multi-Level CTO Course (MLCTO) was kicked off on June 30th in Nice, France.
The main goal of this event is to bring together all the passionate operators in one place, from beginners to experts in a climate of openness and congeniality. Both occasional and regular CTO operators will find this conference to be an opportunity to strengthen their skills and continue their progress in learning new strategies tailored to their level.

APT Medical is honored to be the Ruby sponsor of the congress and introduced our comprehensive PCI products and solutions during the exhibition, which attracts a lot of attention from the experts, especially for our star products Expressman™ guiding extension catheter and CONQUEROR™ Lollipop NC PCTA balloon catheter.

In the live case section, we are more than delighted to watch- Common Antegrade / ADR issues, live case 8, performed by Dr. Kambis Mashayekhi and Dr. Alexandre Avran from Saint-Georges Polyclinic Nice, France on Friday, July 1st, They presented a very long calcified RCA CTO case with a perfect final result. During the case, Expressman™ 5-4F tapered guiding extension catheter with side holes was used for deep intubation into the distal lesion, without compromising antegrade blood flow, in addition, Elong™ 2.6F microcatheter with superior drilling capability was utilized to help get to the lesion safely and efficiently.

"From Confidence to Trust" expresses APT Medical's dedication to bringing more innovative and reliable products and solutions to the world, bringing confidence for clinicians to overcome clinical challenges, and building mutual trust between them and patients, as well as the trust in our quality.

Thank you all who joined us at MLCTO, we hope to see you next year!


The ML CTO ACADEMY is an educational and scientific association dedicated to improving patient care through the support of education, science, research and clinical practice in the field of interventional cardiology, focusing on the treatment of chronic coronary occlusions.